Stryker MedSurg and Neurotechnology: — Goodwill decreased by 4.9% to $11.95B in Q1 2026 compared to the prior quarter.
High levels suggest significant historical M&A activity, while sudden decreases may signal impairment charges due to underperforming acquisitions.
Reflects the intangible asset value recorded when the cost of acquiring businesses within the MedSurg and Neurotechnolog...
Standard across large-cap medical device companies that utilize M&A as a growth strategy.
syk_segment_medsurg_and_neurotechnology_goodwill| Q4 '21 | Q4 '22 | Q4 '23 | Q3 '24 | Q4 '24 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|
| Value | $5.67B | $7.94B | $8.27B | $528.00M | $9.21B | $12.56B | $11.95B |
| QoQ Change | — | +40.0% | +4.2% | -93.6% | >999% | +36.4% | -4.9% |
| YoY Change | — | +40.0% | +4.2% | — | +11.3% | +36.4% | — |